Compare drug alternatives

Aimovig® Alternatives

Aimovig®

(Erenumab)
Aimovig
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig. Aimovig is FDA approved for the following indications: Migraine prevention.

Ubrelvy®

(ubrogepant)
Ubrelvy
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines. Ubrelvy is FDA approved for the following indications: Migraine.

Dosage & Administration

Administration
Subcutaneous
Oral
Dosing
70 mg once monthly or 140 mg once monthly (for some patients)
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
Latin Shorthand
70 mg/mo or 140 mg/mo
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.

Financial Assistance

Copay
$5
$0
Annual Cap
Patient specific maximum benefit.
Maximum savings of $50 per pill for up to 13 prescription fills.
Assistance Expiration
Calendar year
13 prescription fills
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Aimovig
Ubrelvy